Administration of IPA attenuates pro-inflammatory (CD4+IFNγ+IL10−) T cells and increases anti-inflammatory (CD4+IFNγ−IL10+) T cells in the colon in a mouse model of colitis [61]. The gene discussed is CD4; the disease is colitis.